Lisa A. Bukovac, DO, FACOG, explains how placental biomarker testing can identify which patients with suspected preeclampsia require hospitalization and which can be safely monitored.
Lisa A. Bukovac, DO, FACOG
Advertisement
Lisa A. Bukovac, DO, FACOG, Chief clincial officer, Ob Hospitalist Group.
Articles by Lisa A. Bukovac, DO, FACOG
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA working with manufacturers to increase access to estradiol transdermal patches
2
ACOG's 2026-27 respiratory virus immunization recommendations in pregnancy, postpartum
3
Kevin Ault, MD, on the maternal and fetal benefits of COVID-19 and flu vaccination in pregnancy
4
Top headlines in women's health from August 2026
5